Compositions comprising timolol and their use in the treatment of rosacea by topical administration
WO2017220431A1
Fused pyrazole derivatives as jak inhibitors
KR20190018440A
Composition comprising timolol and anti-inflammatory agent
WO2017076990A1
Addition salts of n-[4-(4-{[(1s)-1-(5-methyl-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)ethyl]amino}-7h-pyrrolo[2,3-d]pyrimidin-5-yl)-1h-indol-6-yl]sulfamide
WO2017064068A1
New trpa1 antagonists
WO2017060488A1
New trpa1 antagonists
WO2016202800A1
Pyrrolotriazinone derivatives as pi3k inhibitors
TW201705961A
2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors
